Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,999,281
  • Shares Outstanding, K 76,240
  • Annual Sales, $ 0 K
  • Annual Income, $ -182,390 K
  • EBIT $ -256 M
  • EBITDA $ -252 M
  • 60-Month Beta 1.25
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.69

Options Overview Details

View History
  • Implied Volatility 60.39% ( +9.17%)
  • Historical Volatility 38.09%
  • IV Percentile 79%
  • IV Rank 31.11%
  • IV High 142.33% on 11/24/23
  • IV Low 23.39% on 08/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 31
  • Volume Avg (30-Day) 47
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 915
  • Open Int (30-Day) 2,095

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.87
  • Number of Estimates 10
  • High Estimate -0.59
  • Low Estimate -1.02
  • Prior Year -0.64
  • Growth Rate Est. (year over year) -35.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.34 +5.36%
on 11/19/24
46.00 -14.48%
on 11/08/24
-5.52 (-12.30%)
since 10/18/24
3-Month
37.34 +5.36%
on 11/19/24
46.00 -14.48%
on 11/08/24
-0.17 (-0.43%)
since 08/20/24
52-Week
28.20 +39.50%
on 11/24/23
50.99 -22.85%
on 03/01/24
+10.25 (+35.24%)
since 11/20/23

Most Recent Stories

More News
Xenon to Present at Upcoming Investor Conferences

XENE : 39.34 (+1.26%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 39.34 (+1.26%)
Xenon Reports Q3 2024 Financial Results and Business Update

XENE : 39.34 (+1.26%)
Xenon to Report Q3 2024 Financial Results on November 12, 2024

XENE : 39.34 (+1.26%)
Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

Intra-Cellular ITCI is focused on discovering, developing and commercializing small molecule drugs for treating neuropsychiatric and neurological disorders. The company currently has only one marketed...

ITCI : 84.79 (-0.99%)
XENE : 39.34 (+1.26%)
AXSM : 95.71 (+1.18%)
Xenon Pharmaceuticals: Q2 Earnings Snapshot

Xenon Pharmaceuticals: Q2 Earnings Snapshot

XENE : 39.34 (+1.26%)
Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals: Q1 Earnings Snapshot

XENE : 39.34 (+1.26%)
Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Pharmaceuticals: Q4 Earnings Snapshot

XENE : 39.34 (+1.26%)
Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise, Monday, 11/27/2023

Stocks that traded heavily or had substantial price changes on Monday: Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise

CRNC : 3.35 (+18.79%)
SHOP.TO : 145.34 (-0.45%)
NEM : 43.37 (+0.88%)
XENE : 39.34 (+1.26%)
FCX : 43.89 (+0.43%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 39.34 (+1.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan...

See More

Key Turning Points

3rd Resistance Point 41.01
2nd Resistance Point 40.25
1st Resistance Point 39.80
Last Price 39.34
1st Support Level 38.59
2nd Support Level 37.83
3rd Support Level 37.38

See More

52-Week High 50.99
Fibonacci 61.8% 42.28
Fibonacci 50% 39.60
Last Price 39.34
Fibonacci 38.2% 36.91
52-Week Low 28.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar